A U.K. firm says it has had success in an early test of a weekly vaccine that can prevent allergy attacks caused by the house dust mite. An early trial showed vaccination with the Cytos Biotechnology drug also proved effective for those who have asthma and hay fever.

Full Story:

Related Summaries